ECSP088719A - Procedimiento para preparar conjugados de polietilenglicol solubles en agua de inmunosupresores de macrolidos - Google Patents

Procedimiento para preparar conjugados de polietilenglicol solubles en agua de inmunosupresores de macrolidos

Info

Publication number
ECSP088719A
ECSP088719A EC2008008719A ECSP088719A ECSP088719A EC SP088719 A ECSP088719 A EC SP088719A EC 2008008719 A EC2008008719 A EC 2008008719A EC SP088719 A ECSP088719 A EC SP088719A EC SP088719 A ECSP088719 A EC SP088719A
Authority
EC
Ecuador
Prior art keywords
macrolidos
immunosuppressors
polyethylenglycol
conjugates
procedure
Prior art date
Application number
EC2008008719A
Other languages
English (en)
Inventor
Mahdi Bakir Fawzi
Mark Edward Ruppen
Jianxin Gu
Tianmin Zhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP088719A publication Critical patent/ECSP088719A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen procedimientos para preparar rapamicinas 42-pegiladas incluyendo hacer reaccionar una rapamicina con un agente de acilación en presencia de una lipasa para formar una rapamicina acilada y hacer reaccionar la rapamicina acilada o un derivado de metoxipolietilenglicol en presencia de una base; también se describen procedimientos para preparar tacrolimo y/o ascomicina 32-pegilados utilizando estos pasos
EC2008008719A 2006-03-07 2008-09-05 Procedimiento para preparar conjugados de polietilenglicol solubles en agua de inmunosupresores de macrolidos ECSP088719A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77993906P 2006-03-07 2006-03-07

Publications (1)

Publication Number Publication Date
ECSP088719A true ECSP088719A (es) 2008-10-31

Family

ID=38420553

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008719A ECSP088719A (es) 2006-03-07 2008-09-05 Procedimiento para preparar conjugados de polietilenglicol solubles en agua de inmunosupresores de macrolidos

Country Status (19)

Country Link
US (1) US7605257B2 (es)
EP (1) EP1993610A2 (es)
JP (1) JP2009529050A (es)
KR (1) KR20080106225A (es)
CN (1) CN101394867A (es)
AR (1) AR059740A1 (es)
AU (1) AU2007223963A1 (es)
BR (1) BRPI0708562A2 (es)
CA (1) CA2644156A1 (es)
CR (1) CR10234A (es)
EC (1) ECSP088719A (es)
IL (1) IL193636A0 (es)
MX (1) MX2008011458A (es)
NO (1) NO20083716L (es)
PE (1) PE20080138A1 (es)
RU (1) RU2008134369A (es)
SV (1) SV2009003017A (es)
TW (1) TW200812622A (es)
WO (1) WO2007103348A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577011A1 (en) * 2004-08-10 2006-04-13 Wyeth Cci-779 derivatives and methods of making same
TW200824713A (en) * 2006-10-18 2008-06-16 Wyeth Corp Processes for the synthesis of individual isomers of mono-PEG CCI-779
TW200845960A (en) * 2007-04-05 2008-12-01 Wyeth Corp Wortmannin-rapalog conjugate and uses thereof
IT1394309B1 (it) * 2009-05-22 2012-06-06 Poli Ind Chimica Spa Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus
ES2574522T3 (es) * 2012-06-08 2016-06-20 Biotronik Ag Ésteres 40-O-hidrocarburo cíclico de rapamicina, composiciones y procedimientos
DK2885007T3 (en) * 2012-08-16 2018-12-03 Pfizer Methods for glycoconjugation and compositions
WO2014145780A1 (en) 2013-03-15 2014-09-18 Biosensors International Group, Ltd. Purification of rapamycin derivatives
WO2015081821A1 (zh) * 2013-12-02 2015-06-11 北京键凯科技有限公司 聚乙二醇-多爪寡肽键合的雷帕霉素衍生物
CN109311910B (zh) 2016-03-24 2022-02-01 杜兰教育基金委员会 他克莫司偶联物、其组合物、及其用途
CN108641075B (zh) * 2018-03-05 2019-12-06 江苏千之康生物医药科技有限公司 一类雷帕霉素及其衍生物的双短链聚乙二醇前药及其应用
CN110314236A (zh) * 2018-03-29 2019-10-11 天津键凯科技有限公司 聚乙二醇与雷帕霉素的结合物及其用途
EP4157241A4 (en) * 2020-05-29 2025-01-08 The Regents of the University of California AGENTS AND METHODS FOR THE TREATMENT OF TAUOPATHIES
CN115160559B (zh) * 2021-04-02 2024-02-02 杭州宜生医药科技发展有限公司 一种peg化雷帕霉素化合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
KR100244164B1 (ko) 1997-07-15 2000-03-02 김용옥 수용성 고분자-타크로리무스 접합체 화합물 및 그의 제조 방법
US6331547B1 (en) 1999-08-18 2001-12-18 American Home Products Corporation Water soluble SDZ RAD esters
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
ATE411321T1 (de) 2000-09-19 2008-10-15 Wyeth Corp Wasserlösliche rapamycin-ester
JP4224115B2 (ja) 2004-04-14 2009-02-12 ワイス ラパマイシン42−エステル誘導体の位置特異的合成
PL1735321T3 (pl) 2004-04-14 2009-04-30 Wyeth Corp Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała

Also Published As

Publication number Publication date
AU2007223963A1 (en) 2007-09-13
US7605257B2 (en) 2009-10-20
NO20083716L (no) 2008-10-06
KR20080106225A (ko) 2008-12-04
CN101394867A (zh) 2009-03-25
PE20080138A1 (es) 2008-03-05
BRPI0708562A2 (pt) 2011-06-07
WO2007103348A2 (en) 2007-09-13
EP1993610A2 (en) 2008-11-26
WO2007103348A3 (en) 2008-05-08
CR10234A (es) 2008-10-29
IL193636A0 (en) 2009-05-04
TW200812622A (en) 2008-03-16
RU2008134369A (ru) 2010-04-20
JP2009529050A (ja) 2009-08-13
US20070212371A1 (en) 2007-09-13
AR059740A1 (es) 2008-04-23
MX2008011458A (es) 2008-09-24
SV2009003017A (es) 2009-03-04
CA2644156A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
CR10234A (es) Procedimiento para preparar conjugados de polietilenglicol solubles en agua de inmunosupresores de macrolidos
EP1983783A4 (en) MOBILE STATION AND BASE STATION
EP2056614A4 (en) BASIC STATION AND MOBILE STATION
TW200711504A (en) Methods and apparatus for providing a roaming support system
EP1998586A4 (en) BASIC STATION, MOBILE STATION AND PROCEDURE
PL1734927T3 (pl) Kompozycja pianki pimekrolimusa zawierająca glikol heksylenowy, ewentualnie alkohol oleilowy, dimetyloizosorbid oraz/albo triglicerydy o średniej długości łańcucha
WO2004090108A3 (en) Irna conjugates
EP2091440A4 (en) Biopsy support with sectionable resilient cellular material
EP1733366A4 (en) SYSTEM FOR THE USE OF MOBILE PHONES AS TRAFFIC SENSORS
BRPI0718303A2 (pt) Aparelho da estação de base e método
DE602005008818D1 (de) Härtbare Perfluorpolyetherzusammensetzungen und daraus hergestellte Gummi- oder Gelartikel
EP2068584A4 (en) MOBIL STATION AND BASE STATION
IL186481A0 (en) Supporting handover of mobile terminal
PT2699047E (pt) Estação base e método em sistema de comunicação móvel
EP1906572A4 (en) BASIC STATION EQUIPMENT AND MOBILE STATION EQUIPMENT
EP1946257A4 (en) INSTANT MESSAGING FOR LANGUAGE BETWEEN MOBILES AND DATA PROCESSING EQUIPMENT
DE602006001835D1 (de) Mobiles Endgerät und dazu gehöriges Verfahren zur Kanalkompensation
AU2003230767A8 (en) Methods of promoting cell viability
GB2425889B (en) Shallow trench isolation process and structure
FI20065546A0 (fi) Ajoitusmenetelmä, radiojärjestelmä, tukiasema ja ajoitusmoduuli
EP1736447A4 (en) METHOD AND DEVICE FOR SINTERING POROUS GLASS BASED MATERIAL
EP1768433A4 (en) RADIO BASE STATION AND MOBILE STATION
EP1873184A4 (en) polyether ester
GB2442913B (en) Method and system of accessing a de-keyed base station
SG152252A1 (en) Method for obtaining optically active epoxides and vicinal diols from meso-epoxides